About this trial
This prospective observational study aims to evaluate the effectiveness and safety of different postoperative analgesia methods used in patients undergoing percutaneous nephrolithotomy (PCNL). Analgesia techniques are determined independently by the responsible anesthesiologist as part of routine clinical practice, and the study team does not intervene in treatment decisions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18-65 years
ASA physical status I-III
Undergoing unilateral PCNL
Providing written informed consent
Disqualifiers
Known allergy to local anesthetics
Trial population
Adult patients aged 18 to 65 years undergoing unilateral percutaneous nephrolithotomy (PCNL) at Haseki Training and Research Hospital. All participants are ASA physical status I-III and receive postoperative analgesia according to routine clinical practice.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Cumulative opioid consumption
Cumulative opioid consumption in the first 24 hours
Secondary outcomes
Pain scores at rest and during movement
Pain intensity measured using the Numeric Rating Scale (NRS), a validated 11-point pain scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores represent worse pain
Time to first analgesic request
Time to first analgesic request
Need for rescue analgesics
Need for rescue analgesics
Intraoperative opioid consumption
Intraoperative opioid consumption
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: